Prinova launches nanoparticle-free vitamin D

0
529
cropped shot of mother feeding happy child with porridge while he looking at camera

Global ingredients and premix specialist Prinova has developed a premium line of nanoparticle-free vitamin D powders that will enable food, beverage and nutrition businesses to tap into growing demand for products containing the ‘sunshine vitamin’. Oil-based formats are also available.

The launch comes at a time of intense interest in the micronutrient,  particularly as more evidence emerges of a link between low vitamin D status and severe Covid-19 outcomes. 

Prinova’s vitamin D portfolio comprises vitamin D3 from cholecalciferol, which is manufactured in Europe, and vitamin D2 from ergocalciferol, which is made in the USA and is suitable for vegans. 

In powder form, both are free-flowing and offer high dispersibility despite not containing any anti-caking agents. The absence of these – made possible by a production method exclusive to Prinova – makes them, the  company says, the only nanoparticle-free products of their type available on the market. This is increasingly a key selling point, with consumer concern mounting in relation to the safety of nanoparticles, especially in infant nutrition products.

“…products containing Vitamin D are enjoying a wave of popularity and while this is a great opportunity it also makes the category fiercely competitive”

Vitamins D3 and D2 from Prinova are suitable for a wide range of applications, including infant nutrition, supplements, dairy, beverages, cereals, bars, and sports nutrition. They are non-GMO and Halal certified and offer excellent stability – even at higher temperatures.

Tony Gay, head of technical Sales & NPD for Nutrition Division at Prinova Europe, said: “Products containing Vitamin D are enjoying a wave of popularity and while this is a great opportunity it also makes the category fiercely competitive. Prinova’s vitamins D3 and D2 provide an edge so that manufacturers can create products that address consumers’ concerns and align with their preferences.”